STRUCTURE AND BIOLOGICAL ACTIVITY OF LIPIARMYCIN
Actinoplanes deccanensis ATCC21983, the producer of antibiotics lipiarmycin A3 and A4, furnished also a related antibiotic designated lipiarmycin B, active against Gram-positive bacteria, including anaerobes, and against Neisseria. The structures of the two major components, B3 and B4, were elucidated from their physico-chemical properties, XHand 13C NMRspectra and fast atom bombardmentmass spectra data in comparison with lipiarmycins A3andA4.
Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization.
Lipiarmycin, a metabolite of Actinoplanes deccanensis nov. sp. (PARENTI et al.), has been isolated in pure form. It has a molecular formula C52 CONGRUENT TO 54H74 CONGRUENT TO 76Cl2O19, (M.W. = 1,073 CONGRUENT TO 1,099). From its chemical and physico-chemical characteristics, lipiarmycin can be considered a new antibiotic. Lipiarmycin is highly active against Gram-positive bacteria, including strains resistant to the medically important antibiotics and protects mice experimentally infected with Streptococcus haemolyticus. Liparmycin inhibits growth of susceptible bacteria by interfering with RNA synthesis.
Purpuromycin, a new antibiotic isolated from Actinoplanes ianthinogenes N. sp.
Purpuromycin (C26H18O13) is a new antibiotic isolated from the culture broth of Actinoplanes ianthinogenes proposed as a new species on the basis of its morphological, cultural and physiological characteristics. The antibiotic, obtained as purple crystals, belongs to the naphthoquinone group of antibiotics and resulted to be related to rubromycins. The isolation and purification procedures and the chemico-physical properties of the product are reported. Purpuromycin is active in vitro against Gram-positive bacteria at 0.005-0.02μg/ml, at 1-20μg/ml on Gram-negative bacteria and at 0.2-0.5 μg/ml on fungi.